Show simple item record

Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

dc.contributor.authorTuzun, E.
dc.contributor.authorPehlivan, M.
dc.contributor.authorUlusoy, C.
dc.contributor.authorIcoz, S.
dc.contributor.authorKurtuncu, M.
dc.contributor.authorPetek-Balci, B.
dc.contributor.authorBirday, E.
dc.contributor.authorTurkoglu, R.
dc.contributor.authorAkman-Demir, G.
dc.contributor.authorEraksoy, M.
dc.contributor.authorCoban, A.
dc.date.accessioned2021-03-05T21:50:39Z
dc.date.available2021-03-05T21:50:39Z
dc.identifier.citationKurtuncu M., Tuzun E., Petek-Balci B., Birday E., Coban A., Turkoglu R., Icoz S., Pehlivan M., Ulusoy C., Akman-Demir G., et al., "Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients", 29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Copenhagen, Danimarka, 2 - 05 Ekim 2013, cilt.19, ss.450
dc.identifier.othervv_1032021
dc.identifier.otherav_dad4d5e2-7a97-42a8-8284-325a503cd4eb
dc.identifier.urihttp://hdl.handle.net/20.500.12627/144238
dc.language.isoeng
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectYaşam Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Bilimler
dc.subjectNEUROSCIENCES
dc.subjectKlinik Tıp
dc.subjectKLİNİK NEUROLOJİ
dc.titleReduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients
dc.typeBildiri
dc.contributor.departmentIstanbul Haseki Training & Research Hospital , ,
dc.identifier.volume19
dc.contributor.firstauthorID142971


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record